Company Filing History:
1 out of 23 
1 out of 832,891 Years Active: 2001-2014
Title: Sergio Romagnani: Innovator in Immunotherapy
Introduction
Sergio Romagnani is a prominent inventor based in Florence, Italy. He has made significant contributions to the field of immunotherapy, particularly in the development of methods and compounds that target specific immune responses. With a total of 2 patents, his work has the potential to impact the treatment of allergic diseases and other immune-related conditions.
Latest Patents
Romagnani's latest patents include innovative approaches to immunotherapy. One of his notable inventions is the "Preparation of conjugates comprising adenine derivatives and allergenic proteins and their use for specific immunotherapy of allergenic diseases." This invention focuses on the preparation of adenine derivative active esters and their application in creating stable conjugates with allergenic proteins. This method aims to modulate the T2 response in allergic diseases.
Another significant patent is titled "Methods for detecting, identifying, isolating, and selectively labeling and targeting TH1 lymphocyte by means of the LAG-3 protein." This invention utilizes the LAG-3 protein as a marker to detect and differentiate Th1 lymphocytes from Th2 lymphocytes. The methods described in this patent have implications for diagnosing Th1-mediated diseases and treating conditions such as infectious diseases and cancer.
Career Highlights
Throughout his career, Romagnani has worked with various institutions, including the Università Degli Studi Di Firenze. His research has focused on understanding immune responses and developing therapeutic strategies to address immune-related disorders. His contributions have been recognized in the scientific community, and he continues to be an influential figure in immunology.
Collaborations
Romagnani has collaborated with notable colleagues, including Enrico Maggi and Paola Parronchi. These collaborations have enriched his research and expanded the impact of his inventions in the field of immunotherapy.
Conclusion
Sergio Romagnani's innovative work in immunotherapy showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective treatments for allergic diseases and other immune disorders. His contributions are likely to have a lasting impact on the field of immunology.